Fair Value Measurements

9 Months Ended

Sep. 26, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 26, 2020:

(in millions)	Level 1		Level 2		Total
Assets:
Cash equivalents	$	0.3	$	—	$	0.3
Short-term investments in marketable securities	0.8		—		0.8
Restricted cash	9.1		—		9.1
Derivatives	—		2.6		2.6
Total assets	$	10.2	$	2.6	$	12.8
Liabilities:
Derivatives	$	—	$	3.7	$	3.7
Deferred compensation	0.8		16.5		17.3
Total liabilities at fair value	$	0.8	$	20.2	$	21.0
Liabilities measured at net asset value					10.1
Total liabilities					$	31.1

The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019:

(in millions)	Level 1		Level 2		Total
Assets:
Cash equivalents	$	0.3	$	—	$	0.3
Short-term investments in marketable securities	0.8		—		0.8
Restricted cash	11.6		—		11.6
Derivatives	—		4.2		4.2
Total assets	$	12.7	$	4.2	$	16.9
Liabilities:
Derivatives	$	—	$	3.2	$	3.2
Deferred compensation	1.2		18.8		20.0
Total liabilities at fair value	$	1.2	$	22.0	$	23.2
Liabilities measured at net asset value					8.5
Total liabilities					$	31.7

The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 28, 2019:

(in millions)	Level 1		Level 2		Total
Assets:
Cash equivalents	$	0.2	$	—	$	0.2
Short-term investments in marketable securities	0.8		—		0.8
Restricted cash	11.6		—		11.6
Derivatives	—		11.7		11.7
Total assets	$	12.6	$	11.7	$	24.3
Liabilities:
Derivatives	$	—	$	1.8	$	1.8
Deferred compensation	1.1		20.6		21.7
Total liabilities at fair value	$	1.1	$	22.4	$	23.5
Liabilities measured at net asset value					10.3
Total liabilities					$	33.8

In addition to the items shown in the tables above, refer to Note 7 in the Notes to Consolidated Financial Statements in the 2019 Form 10-K for further information regarding the fair value measurements associated with the Company’s postretirement benefit plans.